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Abstract
Background: The PEACH study is based on an innovative 'telephone coaching' program that has been used effectively
in a post cardiac event trial. This intervention will be tested in a General Practice setting in a pragmatic trial using existing
Practice Nurses (PN) as coaches for people with type 2 diabetes (T2D). Actual clinical care often fails to achieve
standards, that are based on evidence that self-management interventions (educational and psychological) and intensive
pharmacotherapy improve diabetes control. Telephone coaching in our study focuses on both. This paper describes our
study protocol, which aims to test whether goal focused telephone coaching in T2D can improve diabetes control and
reduce the treatment gap between guideline based standards and actual clinical practice.
Methods/design: In a cluster randomised controlled trial, general practices employing Practice Nurses (PNs) are
randomly allocated to an intervention or control group. We aim to recruit 546 patients with poorly controlled T2D
(HbA1c >7.5%) from 42 General Practices that employ PNs in Melbourne, Australia. PNs from General Practices
allocated to the intervention group will be trained in diabetes telephone coaching focusing on biochemical targets
addressing both patient self-management and engaging patients to work with their General Practitioners (GPs) to
intensify pharmacological treatment according to the study clinical protocol. Patients of intervention group practices will
receive 8 telephone coaching sessions and one face-to-face coaching session from existing PNs over 18 months plus usual
care and outcomes will be compared to the control group, who will only receive only usual care from their GPs. The
primary outcome is HbA1c levels and secondary outcomes include cardiovascular disease risk factors, behavioral risk
factors and process of care measures.
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Discussion: Understanding how to achieve comprehensive treatment of T2D in a General Practice setting is the focus
of the PEACH study. This study explores the potential role for PNs to help reduce the treatment and outcomes gap in
people with T2D by using telephone coaching. The intervention, if found to be effective, has potential to be sustained
and embedded within real world General Practice.
Background
The treatment gap and health policy in diabetes
Diabetes has reached epidemic proportions in most coun-
tries [1] including Australia [2]. The incidence of diabetes
is expected to double worldwide in the next twenty years.
The economic costs of diabetes are huge and are doubled
by the onset of complications resulting from poor disease
control. Diabetes is a complex disorder where multifacto-
rial interventions have been proven to improve disease
control and health outcomes. Several major randomised
controlled trials (RCTs) have shown reduction of compli-
cations with more intensive pharmacotherapy for hyper-
tension, dyslipidaemia and hyperglycaemia in type 2
diabetes (T2D)[3]. A recent study compared intensive
hospital-based multi-modality treatment for T2D and
associated cardiovascular risk factors with usual treatment
in primary care and found a 50% reduction in cardiovas-
cular disease (CVD), nephropathy, retinopathy and neu-
ropathy in the intensively treated group [4]. A range of
self-management interventions focusing on patient edu-
cation and empowerment have also been shown to be
effective [5,6].
In Australia, the National Service Improvement Frame-
work (NSIF) for Diabetes states that high quality clinical
care and support are critical to improving diabetes out-
comes [7]. The framework identifies the characteristics of
optimal care as being based on evidence and guidelines,
as well as being patient centred, structured to include
goal-setting and involving PNs in delivering care. In Aus-
tralia and the UK, people with T2D receive the majority of
their care in General Practice. Yet GPs face barriers to pro-
viding structured multidisciplinary care for chronic ill-
nesses such as diabetes. These barriers include the
complexity and time consuming nature of chronic disease
care as well as a lack of clarity about legitimate goals and
outcome measures [8]. GPs' knowledge, skills, attitudes
and beliefs may also significantly alter their approach to
management [9,10]. In addition, people with diabetes
vary in their knowledge and skills, sense of engagement,
expectations of treatment, and consequent behaviour. As
a result there is often a significant treatment and outcomes
gap between clinical diabetes care guidelines and actual
clinical practice in General Practice [11,12]. This gap is
most marked in socio-economically disadvantaged com-
munities [13-15]. The potential role for PNs to help
reduce this treatment and outcomes gap through enhanc-
ing patient self-management as well as intensifying ther-
apy, needs further study.
Educational and psychological interventions
A meta-analysis of 31 RCTs of patient-centred education
and self-management interventions in diabetes reported a
mean 0.75% absolute reduction in HbA1c [5]. Ismail et al.
[6] suggested educational interventions focusing on
knowledge and information need to be distinguished
from psychological interventions that address individuals'
cognitive and emotional functioning and that the latter
alone can reduce HbA1c by 1%. Many of the psychologi-
cal interventions that Ismail et al. reviewed employed
Rollnick & Miller's [16] motivational interviewing tech-
niques based on the Transformational Model of Change
or counseling strategies focused on Bandura's [17] theory
of self-efficacy. Nevertheless, how such interventions have
an effect remains unclear [18] although some experts sug-
gest goal setting based on clinical information may be crit-
ical [19,20]
The Coaching patients On Achieving Cardiovascular 
Health (COACH) intervention
The COACH program uses structured telephone coaching
of patients. It is a pragmatic intervention that primes the
patient to self-manage by adhering to medication and
make relevant behaviour changes. It also, importantly,
encourages patients to take greater initiative in the thera-
peutic alliance, which enables treatment to be appropri-
ately intensified according to clinical practice guidelines
in order to achieve treatment goals. The COACH model
includes a structured training course for coaches and a
series of scheduled and structured telephone sessions with
patients addressing lifestyle issues, medication adherence
and dosing, how to monitor their disease and how to con-
sult with their GP and allied health services. The COACH
intervention has been shown to effectively reduce CVD
risk factors in patients with established CVD in a hospital
setting using trained, dedicated coaches [21,22]. It is an
appropriate model to enhance intensive diabetes treat-
ment because many of the treatment goals are the same.
However, it has not been applied or tested in a commu-
nity setting, nor with PNs acting as coaches. We adapted
the COACH intervention for T2D based on information
derived from a series of focus groups with people with
T2D undertaken to establish whether telephone coaching
by PNs would be an acceptable way of managing diabetes
for our target sampling population in General Practice.BMC Family Practice 2007, 8:20 http://www.biomedcentral.com/1471-2296/8/20
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This qualitative phase of the study, which will be reported
elsewhere, included a trial run of the PEACH study ques-
tionnaires. The PEACH study aims to test whether tele-
phone coaching can reduce the guideline-treatment gap in
people with T2D in a way that meets the characteristics of
optimum care set out in the NSIF [7].
Objectives of the study
Our primary objective is to test the effectiveness of the
COACH program in improving glycaemic control at 12
and 18 months in patients with poorly controlled T2D
(HbA1C >7.5%) compared with usual care only. Our sec-
ondary objective is to assess the impact of the intervention
on other CVD risk factors (total cholesterol, High Density
Lipoprotein (HDL) cholesterol, blood pressure, Body
Mass Index (BMI)), behavioural risk factors (exercise,
smoking and diet) and process of care measures (achieve-
ment of guideline based standards for monitoring, and
intensification of therapy). We also plan to study the role
of a range of potential explanatory variables, including
socioeconomic disadvantage, in predicting outcomes.
Methods/design
The study is a cluster-randomised, open controlled, inter-
vention trial where General Practices in Melbourne with
existing PNs are allocated to one of two groups:
• Intervention group where PNs use the COACH Program
to encourage patients with T2D to undertake intensive
disease self-management in combination with usual GP
care.
￿ Control group where patients with T2D receive usual GP
care only.
Identification and recruitment of practices and patients
Figure 1 shows the recruitment process of practices and
patients into the PEACH study.
Practices
GPs are approached using the membership lists of Divi-
sions of General Practice (Divisions of General Practice
are geographic organisations of GPs established in 1992
by the Government. They are local organisations that
unite GPs and increase their capacity to work co-opera-
tively with each other and other health providers[23]).
The study team approached Divisions of General Practice
in areas of relatively high socioeconomic disadvantage
through metropolitan Melbourne and in 2 large nearby
regional centres.
All GPs on the membership list of participating Divisions
and who are from practices that employ PNs receive an
invitation from the Division with a faxback response
sheet. Interested GPs fax back to the research team their
intention to participate. Non-responders are reminded by
the Division staff with a telephone call one week later. The
research team visits practices who express their intention
to participate, explain the PEACH study in great detail and
provides them with a full information pack describing the
aims, methods and expected outcomes of the study, as
well as consent form. Consent from all participating GPs
and PNs is obtained prior to inclusion in the study. Not
all GPs from the practice need to consent to participate for
the practice to be included in the study. An information
night is held to brief GPs and PNs about the PEACH study
implementation.
Patients
Participating GPs obtain a list of all diabetic patients with
HbA1c ordered by them and measured in the previous 12
months with a value >7.5%, from the local pathology pro-
vider. Once a list of eligible patients (see inclusion and
exclusion criteria below) have been identified, a random
sample of a maximum of 40 patients with HbA1c>7.5%
for each practice is sent a letter inviting them to participate
in the study, along with a pamphlet about the study, a
plain language statement, an expression of interest form,
a brief personal survey collecting demographic informa-
tion and details of duration, treatment and complications
of diabetes. The letter is sent using the practice letter head
and is signed by the patient's GP and the pack includes a
postage paid return stamped envelope addressed to the
research team. A member of the research team provides
support to the practice in the identification and recruit-
ment of eligible patients. Patients respond by returning
the expression of interest form to the research team. All
patients, including those who decline, are asked to return
the brief personal survey with their response to the letter,
allowing a comparison of the participant and non-partic-
ipant groups. All patients who indicate interest in partici-
pating have their details forwarded to their practice and
the Practice Nurse contacts the patient to arrange a face-to-
face interview at which the study is fully explained and
consent is obtained. If patients consent to be included,
baseline assessment is undertaken at that face-to-face
interview. Patients who have not responded receive a
reminder call from the Practice Nurse. If the practice has
more than 40 eligible patients, further rounds of ran-
domised mail outs and reminder calls continue until the
required number of patients per practice is recruited. A
further recruitment strategy of searching practice database
to identify eligible patients who had their pathology tests
done elsewhere is employed to minimise selection bias
and reach recruitment targets of patients with diabetes.
Inclusion and exclusion criteria
Practices with a practice nurse are eligible to participate,
and must achieve a minimum recruitment of five patients
to the study to continue. Patients with T2D are eligible toBMC Family Practice 2007, 8:20 http://www.biomedcentral.com/1471-2296/8/20
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Flowchart of PEACH study recruitment process Figure 1
Flowchart of PEACH study recruitment process.
Website info + newsletter
GP Divisions’ database searching
Mail-out invitation to practices that employ a practice nurse
Follow-up phone calls to practices
Practice visits by research team to explain study and to obtain informed consent
 Participating GP Divisions
Generate list of patients from pathology results
INCLUSION CRITERIA:
- T2D patients >18yo
- HbA1c>7.5% in the last 12m
EXCLUSION CRITERIA:
- Not contactable by phone
- Have a complex debilitating medical conditions e.g. severe mental 
illness, end-stage cancer
- Do not provide consent.
Mail out invitation letters to eligible patients according to random order list
Mail out invitation 
letters to the next 
eligible patients on the 
list until target has been 
reached or identify 
eligible patients on 
practice database and 
send invitation letters
Patients arrange a 1-hour
appointment with Practice Nurse:
- Explain study and obtain 
informed consent




Cluster randomisation of practicesBMC Family Practice 2007, 8:20 http://www.biomedcentral.com/1471-2296/8/20
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participate if they are >18 years, their most recent HbA1c
is greater than 7.5% and they are receiving care from a
General Practice that employs a Practice Nurse and is
located in one of the participating Divisions of General
Practice. Patients are excluded if they are not contactable
by telephone, have a complex debilitating coexisting med-
ical condition (e.g. mental illness, end-stage cancer), or do
not provide signed consent. Patients from non-English
speaking backgrounds are eligible and are able to utilise a
free telephone interpreting service to find out more infor-
mation about the study and throughout the data collec-
tion and intervention phases.
Baseline assessment
Baseline assessment is conducted by the Practice Nurse
and takes approximately one hour to complete. Patient
written consent is obtained prior to undertaking baseline
assessment. Baseline assessment includes data collected
by the Practice Nurse at interview (patient knowledge of
appropriate testing and goals for risk factors, smoking sta-
tus, current exercise levels and a dietary history using a val-
idated food frequency questionnaire [24]), from the
patient file (treatment, test frequency and most recent
pathology results), and patient self report data (diabetes
self efficacy scale [25], the diabetes support scale[26], a
quality of life scale [27] and a measure of depression
[28]). Patients are instructed to arrange baseline testing
for HbA1c, total and HDL cholesterol, and renal function
at their usual local pathology laboratory. Follow up tests
will all be done at the patients' usual pathology labora-
tory. All participating laboratories use HbA1c assay meth-
ods that are DCCT aligned [29] and participate in a
regional quality assurance program for HbA1c assays.
Outcome assessment
Data collected at baseline, including primary and second-
ary outcome measures, will be collected again at 12 and
18 months post-intervention for both the intervention
and control groups. Study team nurses blinded to the
group allocation of participants will collect 12 month and
18 month follow up data by face-to-face interview with
the patient. We will also access administrative data sets in
relation to health service use and cost.
Randomisation
General Practices are randomised to either the interven-
tion or control group after all baseline assessments are
completed (figure 2). Block randomisation with random
block sizes, stratified according to the organisational and
financial arrangements of the general practices (fee-for-
service private practice or state government funded com-
munity health centre status) and whether they are partici-
pating in the National Primary Care Collaboratives
Program (A national pilot quality improvement program
aimed at improving quality of chronic disease care and
currently involving approximately 7% of general prac-
tices) is used to allocate practices to study groups. The
allocation sequence is computer generated by the statisti-
cian from the research team, blinded to the identity of the
general practices. Following randomisation, practices are
informed by a letter from the Chief Investigator of
whether their practice will be in the intervention or con-
trol group.
The intervention
Practice Nurses in practices randomised to intervention
group undertake a two-day training program in telephone
coaching for diabetes using the adapted COACH manual.
The telephone coach intervention addresses lifestyle and
pharmacological management of hyperglycaemia, and
specifically focuses on achieving HbA1c of less than 7% as
the goal of treatment. Goals of treatment for the second-
ary outcomes are also given in table 1. The treatment algo-
rithm given in table 1 is adapted from the Steno-2 Study
[30] and is virtually the same as previously used in man-
agement of cardiovascular risk factors in patients with cor-
onary heart disease [21,22].
The COACH Program includes a letter welcoming the
patient to the COACH Program and providing written
information about coaching sessions. Patients also receive
a one-page chart of risk factor targets and a folder with the
name and contact details of their Practice Nurse "coach".
This folder is designed to store all future COACH Program
correspondence. In addition, the Practice Nurse coach
places the same one-page chart of risk factor targets and
notification of details of patient enrolment in the patient's
file for when they next see their GP. The 'Coaching Pro-
gram' involves five coaching telephone calls at six weekly
intervals in the first 6 months, two coaching telephone
calls at two monthly intervals between 6–12 months, a
face to face coaching session at 12 months and one coach-
ing call at 15 months. Intervention group patients con-
tinue to receive usual General Practice care from their GP
which can include referral to diabetes educators, dietitians
and diabetes specialists that form part of standard diabe-
tes care for patients of that practice.
Patients are coached according to the COACH Model, a
process of continuous quality improvement which
involves coaching the patient to go to their doctor and
obtain measurement of their risk factors and to be
informed of the results of these measurements, education
regarding risk factor targets, negotiation of a plan of
action to achieve the target that includes focus on both
medication and lifestyle and subsequent monitoring of
progress by the patients toward the achievement of the
target level. This quality improvement cycle is a key fea-
ture of the COACH Program – each coaching session is
used as the foundation for the next coaching session.BMC Family Practice 2007, 8:20 http://www.biomedcentral.com/1471-2296/8/20
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There is no pre-set time frame for coaching sessions. The
length of the calls is determined by the length of time the
"coach" needs to establish a plan of action with the
patient to be achieved by the next coaching session.
Patients are able to contact their Practice Nurse coach
between coaching sessions, for questions and further
information as required. A specific software package
designed for the COACH program is used in conjunction
with the telephone coaching sessions to generate written
reports for the patient summarising each verbal coaching
session, and to inform the "coach" for the next session.
Reports are posted to the patients and a copy is placed in
each patient's file. Practice Nurses are paid for their train-
ing time and for their coaching time.
Table 1: Treatment algorithm for PEACH study participants adapted from the Steno-2 Study [30].
Risk Factor Treatment Goal
HbA1c <7%
Total cholesterol <4.0 mmol/L
Blood pressure <130 mmHg for systolic and <80 mmHg for diastolic
Physical activity Light to moderate activity for 30 minutes or more on most or all days a week
Smoking Smoking cessation
Saturated fat <8% of total daily energy intake
Aspirin Low dose of aspirin
Flowchart of PEACH study intervention process Figure 2
Flowchart of PEACH study intervention process.
Practice cluster randomisation with stratification based on fee-for-service private 
practice or state government funded community health centre status
All participants have a 1-hour appointment with study nurses 
to collect 12-month follow-up data 
CONTROL:
- Usual GP care 
INTERVENTION:
- Usual GP care 
- Practice Nurses are trained to deliver 
COACH program by telephone (and 
1 face to face) over 18 months
All participants have a 1-hour appointment with study nurses
to collect 18-month follow-up data 
Baseline assessments of consented participantsBMC Family Practice 2007, 8:20 http://www.biomedcentral.com/1471-2296/8/20
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Quality assurance
The research team provides on-site assistance to the PN in
their first two baseline interviews and questionnaire
administration to ensure quality of data collection. All
Practice Nurses who deliver the Coach intervention attend
the two-day Coach training. In addition, the "Head
Coach" (MV) monitors the first telephone coaching and
random subsequent telephone coaching. A checklist and
regular constructive feedback are provided to all Practice
Nurses. A sub-sample of the Practice Nurses, GPs and
patients involved in the study will be asked to participate
in a semi-structured interview at the conclusion of the
study to understand factors influencing variation in
implementation of the intervention.
Sample size calculations
The unit of randomisation in this RCT is the general prac-
tice. A total of 546 patients (13 patients per practice) from
42 general practices will be required (273 in each arm) to
show an absolute 0.5% or greater reduction in mean
HbA1c in the intervention arm compared with usual GP
care group. The sample size allows for a design effect of
1.4 due to the increased variance of recruiting patients
within practices and an attrition rate of 20% over 18
months and overall attrition rate of 30% over 3 years in
anticipation of an extension of the study for another 18
months pending funding. Calculations are based on a two
sample t-test for means, with a standard deviation of 1.44
(this is based on results from a previous diabetes project
in General Practice in the region involving 1,088 diabetes
patients), 80% power and significance level at 5% for a
two sided test. The design effect is based on a conservative
estimate of the intra-cluster correlation (ICC) for HbA1c
of 0.05.
Data collection, monitoring and analysis
Descriptive statistics will be used to summarise general
practice, practice nurse and patient factors for the two
study groups and to check for any imbalance in baseline
variables between control and intervention group. GP
practice will be set as the primary sampling unit. Out-
comes between study groups will be compared to assess
the effect of the intervention. Primary and secondary out-
comes will be analysed using marginal models using Gen-
eralised Estimating Equations with information sandwich
(robust) standard errors to allow for the effect of cluster-
ing of patients within general practices. Analysis will be
'intention to treat' and where appropriate regression anal-
ysis will be adjusted for baseline outcome measure and
any baseline variables that are imbalanced between the
two study groups. Sensitivity analysis will examine the
effect of loss to follow-up on the intervention effect.
Exploratory analyses are also planned to examine the
effect of explanatory factors (e.g. socio-demographic fac-
tors such as education level or employment status of
patients) on the outcome.
Trial organization and management
The study has received ethics approval from the Human
Research Ethics Committee of the University of Mel-
bourne. No significant risks to participants are antici-
pated. As the study is unblinded and low risk a data
monitoring committee is unnecessary.
A study reference group consisting of representatives of
the three main Divisions of General Practice involved, as
well as Diabetes Australia (a national not-for profit organ-
isation offering assistance to people with diabetes, to
health professionals and providing input into national
policies) and the Australian Practice Nurses Association
has been formed and meets quarterly for the duration of
the study to provide important contextual advice. Eight
T2D patients who have participated in the qualitative
phase formed a consumer reference group and will meet
biannually to provide additional consumer input to the
study. The chief investigators meet monthly to oversee
implementation of the study.
Discussion
One of the strengths of this study is that it is evaluating an
intervention that links a combined educational and psy-
chological intervention focusing on both self manage-
ment and a strengthening of the therapeutic alliance in
intensifying treatment. This combination of strategies and
the focus of the telephone coaching maximises the poten-
tial impact of our intervention based on preceding reviews
of non-pharmacological interventions [5,6] and the dem-
onstrated efficacy of intensive medical therapy[31]. The
principles behind the modified COACH program have
been tested for face validity as an acceptable mode of dia-
betes care in focus groups in the early phases of our study.
Telephone coaching was seen as an acceptable adjunct to
usual practice based care. A further strength of our study is
that it specifically sets out to recruit patients from areas of
socioeconomic disadvantage and non-English speaking
backgrounds. These groups are often not well represented
in intervention studies for a range of reasons, making the
findings less generalisable to these groups. Our study will
potentially provide evidence of effectiveness of an inter-
vention not only for reducing the treatment and outcomes
gap in diabetes care, but also for improving equity of
health outcomes.
The setting in general practice and the use of existing prac-
tice nurses in a cluster randomised design ensures rigour
of evaluation design but also relevance and generalisabil-
ity of the findings to the general practice setting. The
present study also provides the opportunity to study an
intervention over a longer period of time than is usual inBMC Family Practice 2007, 8:20 http://www.biomedcentral.com/1471-2296/8/20
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trials of this nature. Reviews have found that the effect of
many chronic disease interventions is not sustained when
contact for the intervention finished[5,32]. In the previ-
ous study of coaching for CVD in hospital patients choles-
terol lowering in the intervention group was also not
maintained when coaching was completed (unpublished
data M Vale, J Best). Critical to this notion of sustainabil-
ity is the setting and embedded nature of our study. Bas-
ing the study in General Practices and using existing
Practice Nurses as coaches offers the opportunity to
develop evidence on the organisation of work and roles
for the rapidly expanding Practice Nurse workforce. Our
study will test the potential for integrating the program
into the General Practice setting and to maximise cost-
effectiveness and sustainability.
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